144 related articles for article (PubMed ID: 20633801)
1. Malignant melanoma: molecular cytogenetics and their implications in clinical medicine.
Junkins-Hopkins JM
J Am Acad Dermatol; 2010 Aug; 63(2):329-32. PubMed ID: 20633801
[No Abstract] [Full Text] [Related]
2. New therapeutic options in the medical management of advanced melanoma.
Lutzky J
Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
[TBL] [Abstract][Full Text] [Related]
3. Melanoma.
Moschos SJ; Konstantinopoulos PA; Kirkwood JM
Cancer Chemother Biol Response Modif; 2005; 22():563-90. PubMed ID: 16110629
[No Abstract] [Full Text] [Related]
4. [Kinase inhibitors for the therapy of malignant melanoma].
Becker JC; Schrama D; Bröcker EB; Houben R
J Dtsch Dermatol Ges; 2005 Oct; 3(10):762-7. PubMed ID: 16194153
[TBL] [Abstract][Full Text] [Related]
5. The new arms race against melanoma.
Lejeune FJ
Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449
[No Abstract] [Full Text] [Related]
6. Molecularly targeted therapy for melanoma: current reality and future options.
Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
[TBL] [Abstract][Full Text] [Related]
7. Prospects for non-immunological molecular therapeutics in melanoma.
Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
[TBL] [Abstract][Full Text] [Related]
8. Genetics of melanoma tumorigenesis.
Singh M; Lin J; Hocker TL; Tsao H
Br J Dermatol; 2008 Jan; 158(1):15-21. PubMed ID: 18047516
[TBL] [Abstract][Full Text] [Related]
9. Melanoma genetics: the other side.
Bis S; Tsao H
Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
[TBL] [Abstract][Full Text] [Related]
10. [Gene abnormalities in melanoma and signal transduction antagonists].
Takada M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):453-7. PubMed ID: 23894754
[No Abstract] [Full Text] [Related]
11. New research advances for treating metastatic melanoma.
Minutilli E
Int J Dermatol; 2010 Jun; 49(6):712-4. PubMed ID: 20618481
[No Abstract] [Full Text] [Related]
12. [Molecular biology of melanoma--1997].
Zlotogorski A; Peretz T
Harefuah; 1997 Jun; 132(12):855-8. PubMed ID: 9264193
[No Abstract] [Full Text] [Related]
13. Mutated ERBB4: a novel drug target in metastatic melanoma?
Kurppa K; Elenius K
Pigment Cell Melanoma Res; 2009 Dec; 22(6):708-10. PubMed ID: 19735458
[No Abstract] [Full Text] [Related]
14. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
[No Abstract] [Full Text] [Related]
15. [Epidemiology of malignant melanoma of the skin].
Berndt H
Arch Geschwulstforsch; 1974; 44(3):267-77. PubMed ID: 4460956
[TBL] [Abstract][Full Text] [Related]
16. [Testing of individual sensitivity to drugs in human malignant melanoma].
Czownicki Z
Pol Tyg Lek; 1988 Dec; 43(50):1627-30. PubMed ID: 3256805
[No Abstract] [Full Text] [Related]
17. [Prognostic significance of DNA ploidy in disseminated malignant skin melanoma and the effectiveness of interleukin-2 (IL-2) treatment].
Novik AV; Novik BI; Moiseenko VM
Vopr Onkol; 2007; 53(2):164-9. PubMed ID: 17663169
[TBL] [Abstract][Full Text] [Related]
18. [Malignant melanoma: local perfusions].
Pettavel J
Pathol Biol (Paris); 1990 Oct; 38(8):870-1. PubMed ID: 2274394
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of malignant melanoma].
Veronesi U; Bajetta E
Cancro; 1973; 26(5):307-13. PubMed ID: 4793832
[No Abstract] [Full Text] [Related]
20. Clinical characteristics of malignant melanoma.
Laporte M
Acta Chir Belg; 1998 Jun; 98(3):139-40. PubMed ID: 9689976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
